High Purity Liquid 4-Diethylamino-2-Butynyl Acetate Industrial Purity for Pharma Synthesis
- Synthetic Efficiency: Optimized acetylation routes maximize reaction yields and minimize downstream purification costs.
- Logistical Stability: Drum-level packaging ensures safe transit and long-term chemical stability for tonnage quantities.
- Regulatory Alignment: REACH compliant manufacturing processes support global regulatory submissions and audits.
In the competitive landscape of pharmaceutical intermediate manufacturing, consistency is the primary driver of commercial viability. 4-(Diethylamino)but-2-ynyl Acetate (CAS: 22396-77-6) serves as a critical chemical building block in the production of anticholinergic agents such as Oxybutynin. For process chemists and procurement officers, securing a supply chain that guarantees batch-to-batch consistency is non-negotiable. As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. delivers this key Oxybutynin intermediate with rigorous quality controls designed to meet the demanding specifications of modern organic synthesis.
Supply chain volatility often forces manufacturers to compromise on specifications. However, utilizing sub-standard intermediates can lead to significant yield loss during the coupling reaction with cyclohexylphenyl glycolic acid. Our facility focuses on maintaining a high purity liquid profile that reduces the burden on downstream purification steps, ensuring that your final API meets stringent pharmacopeial standards.
Defining Industrial Purity Standards for Intermediates
Establishing a robust quality baseline begins with understanding the impurity profile inherent to the acetylation process. The standard synthesis route involves the reaction of 4-diethylamino-2-butyn-1-ol with acetic anhydride or acetic acid under catalytic conditions. While this process is well-documented, variations in temperature control and catalyst loading can introduce esters, unreacted alcohols, or polymeric byproducts.
At NINGBO INNO PHARMCHEM CO.,LTD., we define our quality parameters not just by assay percentage, but by the absence of specific critical impurities that interfere with subsequent coupling reactions. When sourcing high-purity industrial purity, buyers should prioritize suppliers who provide detailed chromatographic data rather than simple titration results. Our manufacturing process employs fractional distillation under reduced pressure to isolate the target fraction, ensuring that the 4-(Diethylamino)but-2-yn-1-yl acetate delivered to your facility is ready for immediate use in sensitive nucleophilic substitutions.
Analytical Methods for High Purity Liquid Verification
Verification of chemical identity and potency requires advanced analytical instrumentation. For R&D teams validating incoming raw materials, reliance on a single method is insufficient. We recommend a multi-modal approach involving Gas Chromatography (GC) for volatile impurities and High-Performance Liquid Chromatography (HPLC) for non-volatile residues.
Our internal quality control laboratory utilizes GC-FID to quantify the main peak area, typically targeting >98.5% area normalization. Furthermore, water content is strictly monitored via Karl Fischer titration, as excess moisture can hydrolyze the acetate group or interfere with base-catalyzed coupling steps. Every shipment is accompanied by a batch-specific COA that details these parameters, allowing your quality assurance team to verify compliance before the material enters the production line. This transparency is essential for maintaining pharma grade standards throughout the supply chain.
Comparing 98% Purity Against Market Standard 95%
Procurement decisions often hinge on bulk price comparisons, but the total cost of ownership must account for processing efficiency. A material supplied at 95% purity may appear cost-effective initially, but the additional 5% impurity load can consume reagents, foul catalysts, and reduce the overall yield of the final API. In the synthesis of Oxybutynin, where stereochemistry and purity are paramount, starting with a higher grade intermediate mitigates the risk of racemization or side reactions.
Our data indicates that upgrading from standard technical grade to our process-scale purity grade can improve overall reaction yield by 3-5%. This gain often offsets the marginal difference in raw material cost. For executives evaluating commercial viability, this efficiency translates to higher throughput and reduced waste disposal costs. We structure our pricing models to support long-term partnerships, ensuring that global manufacturer reliability is matched by economic feasibility.
| Parameter | Specification | Test Method |
|---|---|---|
| CAS Number | 22396-77-6 | N/A |
| Chemical Name | 4-(Diethylamino)but-2-ynyl Acetate | N/A |
| Molecular Formula | C10H17NO2 | N/A |
| Assay (GC Area) | > 98.5% | GC-FID |
| Water Content | < 0.5% | Karl Fischer |
| Appearance | Clear Colorless to Pale Yellow Liquid | Visual |
| Packaging | 25kg / 200kg Drum | N/A |
Scalability is the cornerstone of our production capability. Whether you require kilogram quantities for clinical trial material or tonnage quantities for commercial launch, our infrastructure is designed to scale without compromising quality. We understand that regulatory compliance extends beyond the chemical itself; it encompasses the entire manufacturing process and documentation trail. Our facilities are audited regularly to ensure adherence to international safety and environmental standards.
To ensure seamless integration into your supply chain, we invite you to contact our technical sales team for a batch-specific COA, SDS, or bulk pricing quote. Partnering with a dedicated manufacturer ensures that your production schedules remain uninterrupted and your quality targets are consistently met.